News

Earnings Estimate Revisions for ANI For the fiscal year ending December 2024, this drugmaker is expected to earn $5.02 per share, which is a change of 6.6% from the year-ago reported number.
Participating Ani-May retailers in Europe are offering customers a weekend with VIP access to Crunchyroll's Expo booth, which will take place from July 11-14 at Parc des Expositions de Villepinte.
ANI Pharmaceuticals (ANIP) is on the list of such stocks currently recommended by our proprietary system. In addition to a favorable Growth Score, it carries a top Zacks Rank. Research shows that ...
Clearly, options traders are pricing in a big move for ANI Pharmaceuticals shares, but what is the fundamental picture for the company? Currently, ANI Pharmaceuticals is a Zacks Rank #1 (Strong ...
Has ANI Pharmaceuticals (ANIP) been one of those stocks this year? By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might be able to answer that ...